VCAN and neoplasm: Versican silencing improved the antitumor efficacy of endostatin by alleviating its induced accumulation of myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs) and inflammatory cytokines in the tumor microenvironment (11).